Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK.

Journal of medical microbiology - 1 Dec 2013

Ferguson Graeme D, Gadsby Naomi J, Henderson Sarah S, Hardie Alison, Kalima Pota, Morris Andrew Conway, Hill Adam T, Cunningham Steve, Templeton Kate E

Abstract excerpt

Mycoplasma pneumoniae has a cyclical, epidemic pattern of infection and the most recent epidemic occurred in Europe in 2011. Macrolides are recommended for the treatment of M. pneumoniae respiratory tract infection, but macrolide resistance has been reported at low levels in Europe. The aim of the study was to examine the clinical impact of the recent M. pneumoniae epidemic in a hospital setting in Scotland and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Macrolides

Share to Mycoplasma Infections

Share to Mycoplasma pneumoniae

Share to Pneumonia, Mycoplasma

Share to RNA, Ribosomal, 23S

Share to Scotland

Source

Identifiers

PMID: 24008501
DOI: 10.1099/jmm.0.066191-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK.PMID 24008501Read ↗

Increased incidence of Mycoplasma pneumoniae infection in England and Wales in 2010: multiocus variable number tandem repeat analysis typing and macrolide susceptibilitySemantic proximity Read ↗

Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.Semantic proximity Read ↗

Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance.Semantic proximity Read ↗

Mycoplasma pneumoniae from the Respiratory Tract and BeyondSemantic proximity Read ↗

<i>Mycoplasma Pneumoniae</i> : Susceptibility and Resistance To AntibioticsSemantic proximity Read ↗

Molecular insights into macrolide resistant Mycoplasma pneumoniae isolates from outpatient clinics in Tehran, Iran.Semantic proximity Read ↗

Association analysis of Mycoplasma pneumoniae 23S rRNA gene mutation with refractory Mycoplasma pneumoniae pneumonia in children.Semantic proximity Read ↗

Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children.Semantic proximity Read ↗

Drug Resistance Mechanisms of<i>Mycoplasma pneumoniae</i>to Macrolide AntibioticsSemantic proximity Read ↗

Pneumonia Characteristics of Hospitalized Children Infected with Macrolide-Resistant Mycoplasma PneumoniaeSemantic proximity Read ↗

Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.Semantic proximity Read ↗

Low Incidence of Macrolide-Resistant Mycoplasma pneumoniae between April 2016 and March 2017 in Akita Prefecture, Japan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.